Intervention
CAR-T cell immunotherapy
ClinicalTrials.gov intervention label
Clinical trials
3 shownClinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate CancerNCT05354375 · 2022-12-01
RECRUITINGAutologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesNCT03638206 · 2018-03-01
UNKNOWNA Clinical Research of CAR T Cells Targeting EpCAM Positive CancerNCT03013712 · 2017-01-01
UNKNOWNCommon conditions
Gastric Cancer2Pancreatic Cancer2B-cell Acute Lymphoblastic Leukemia1Colon Cancer1Colorectal Cancer1Esophageal Carcinoma1Esophagus Cancer1Glioma1Hepatic Carcinoma1Hepatoma1Immunotherapy1Lung Cancer1Lymphoma1Melanoma1Mesothelioma1Multiple Myeloma1Myeloid Leukemia1Ovarian Cancer1Prostate Cancer1Renal Carcinoma1Synovial Sarcoma1
Leading sponsors
Trial status mix
UNKNOWN2
RECRUITING1
Phase mix
PHASE13
PHASE22
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.